Carsgen Therapeutics is a biopharmaceutical company with operations in China and the U.S. that focuses on innovative CAR T-cell therapies for the treatment of hematological malignancies and solid tumors.
The company's vision is to become a global biopharmaceutical leader, bringing innovative and differentiated cell therapies to cancer patients worldwide with the goal of making cancer curable.
Generated from the website